Get started
Author

Ken M. Kunisaki

Observed names: K. M. Kunisaki, K.M. Kunisaki, KEN KUNISAKI, KEN M KUNISAKI, KM Kunisaki, Ken M. Kunisaki, Ken Kunisaki, Ken M Kunisaki, KenM. Kunisaki, Kenneth M. Kunisaki, Kunisaki, K.M., Kunisaki, KM, Kunisaki, Ken M, Kunisaki, Ken M.
Observed institutions: University of Copenhagen, University of Minnesota, United States Department of Veterans Affairs, Mayo Clinic, Veterans Health Administration, Salem VA Medical Center, Copenhagen University Hospital, Rigshospitalet, University of Alabama at Birmingham, Boise VA Medical Center, Birmingham VA Medical Center, Minneapolis VA Health Care System, University of Minnesota Medical Center, Minneapolis VA Medical Center, Research Institute of the McGill University Health Centre, McGill University
ORCID: 0000-0001-8644-2827
Observed ORCID: 0000-0001-8644-2827
OpenAlex ID: A5100776219
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
2009 · Ken M Kunisaki, Edward N Janoff · The Lancet Infectious Diseases · 516
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease
2016 · Mark T. Dransfield, Ken M. Kunisaki, et al. · American Journal of Respiratory and Critical Care Medicine · 356
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial
2018 · Ken M. Kunisaki, Mark T. Dransfield, et al. · American Journal of Respiratory and Critical Care Medicine · 354
Metoprolol for the Prevention of Acute Exacerbations of COPD
2019 · Mark T. Dransfield, Helen Voelker, et al. · New England Journal of Medicine · 183
PDF
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
2019 · Richard T Davey, Eduardo Fernández-Cruz, et al. · The Lancet Respiratory Medicine · 127
PDF
Vitamin D Levels and Risk of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
2011 · Ken M. Kunisaki, Dennis E. Niewoehner, et al. · American Journal of Respiratory and Critical Care Medicine · 99
Vitamin D status and longitudinal lung function decline in the Lung Health Study
2010 · K.M. Kunisaki, D.E. Niewoehner, et al. · European Respiratory Journal · 97
PDF
Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy
2017 · Meghan E. Fitzpatrick, Ken M. Kunisaki, et al. · AIDS · 88
Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
2022 · Mark T. Dransfield, Gerard J. Criner, et al. · Journal of the American Heart Association · 80
PDF
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
2008 · Ken M. Kunisaki, Kathryn L. Rice, et al. · Therapeutic Advances in Respiratory Disease · 71
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function
2021 · Carrie L. Pistenmaa, P. Nardelli, et al. · CHEST Journal · 54
PDF
HIV-associated lung disease
2023 · Ioannis Konstantinidis, Kristina Crothers, et al. · Nature Reviews Disease Primers · 49
The relationship between oral health and COPD exacerbations
2019 · Arianne K Baldomero, Mariam Siddiqui, et al. · International Journal of COPD · 49
PDF
Supplemental vitamin D and physical performance in COPD: a pilot randomized trial
2013 · Ken Kunisaki, Bjerk, et al. · International Journal of COPD · 49
PDF
Chronic obstructive pulmonary disease in HIV
2020 · Katerina Byanova, Ken M. Kunisaki, et al. · Expert Review of Respiratory Medicine · 46
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial
2016 · Ken M Kunisaki, Dennis E Niewoehner, et al. · The Lancet Respiratory Medicine · 44
Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers
2021 · Stefanie E. Mason, Rafael Moreta-Martinez, et al. · CHEST Journal · 42
PDF
High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial
2016 · Dennis Niewoehner, Kara Johnson, et al. · International Journal of COPD · 42
PDF
Vitamin D Concentrations and Obstructive Sleep Apnea in a Multicenter Cohort of Older Males
2016 · Umesh Goswami, Kristine E. Ensrud, et al. · Annals of the American Thoracic Society · 41
Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study
2020 · Ken M Kunisaki, Davide De Francesco, et al. · Open Forum Infectious Diseases · 40
Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs
2016 · M. Drummond, Ken Kunisaki, et al. · Seminars in Respiratory and Critical Care Medicine · 40
Pulmonary function in an international sample of HIV ‐positive, treatment‐naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START ) trial
2015 · KM Kunisaki, DE Niewoehner, et al. · HIV Medicine · 40
Lung function in men with and without HIV
2020 · Ken M. Kunisaki, Mehdi Nouraie, et al. · AIDS · 39
Occurrence of Accelerated Epigenetic Aging and Methylation Disruptions in Human Immunodeficiency Virus Infection Before Antiretroviral Therapy
2020 · Chen Xi Yang, Emma Schon, et al. · The Journal of Infectious Diseases · 38
PDF
Works count: 206
Citation count: 4,082
H-index: 31
I10-index: 86
Year
Topic
Type